Triple-negative breast cancer arising in a fibroadenoma in BRCA 1 mutated patient

被引:1
|
作者
Brunetti, Nicole [1 ,4 ]
Valente, Irene [2 ]
Pitto, Francesca [3 ]
Calabrese, Massimo [3 ]
机构
[1] Univ Genoa, Dept Hlth Sci DISSAL, Genoa, Italy
[2] AOU Parma Hosp, Parma, Italy
[3] IRCCS Hosp Policlin San Martino, Genoa, Italy
[4] Univ Genoa, Dept Hlth Sci DISSAL, Via Antonio Pastore 1, Genoa, Italy
关键词
BRCA; breast cancer on fibroadenoma; triple-negative breast cancer; CARCINOMA;
D O I
10.4103/jmu.jmu_83_21
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We describe the case of a 35-year-old woman who comes to our institute with a palpable lump on her left breast. Clinically the mass was mobile, nontender and with no nipple discharge. Sonography revealed a circumscribed, oval-shaped, and hypoechoic mass, suggestive of a benign lesion. We performed an ultrasound-guided core needle biopsy that demonstrated multiple foci of high-grade (G3) ductal carcinoma in situ arising on fibroadenoma (FA). Subsequently, the patient had surgical excision of the mass with a final diagnosis of triple-negative breast cancer arising on FA. After diagnosis, the patient performs a genetic test that detects the BRCA 1 gene mutation. A review of the literature demonstrated only two cases of triple-negative breast cancer on FA. In this report, we describe another such case.
引用
收藏
页码:63 / 65
页数:3
相关论文
共 50 条
  • [1] BRCA1 methylation in triple-negative breast cancer
    Kawachi, A.
    Okochi-Takada, E.
    Shimoi, T.
    Shimomura, A.
    Kodaira, M.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Ushijima, T.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2015, 26 : 28 - 29
  • [2] Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast Cancer
    Gardi, Nilesh
    Chaubal, Rohan
    Parab, Pallavi
    Pachakar, Sunil
    Kulkarni, Suyash
    Shet, Tanuja
    Joshi, Shalaka
    Kembhavi, Yogesh
    Chandrani, Pratik
    Quist, Jelmar
    Kowtal, Pradnya
    Grigoriadis, Anita
    Sarin, Rajiv
    Govindarajan, Raman
    Gupta, Sudeep
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (02): : 404 - 417
  • [3] BRCA1 testing for triple-negative breast cancer
    Bennet, Neil
    LANCET ONCOLOGY, 2012, 13 (04): : E143 - E143
  • [4] Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models
    Park, Hyung Seok
    Lee, Jeong Dong
    Kim, Jee Ye
    Park, Seho
    Kim, Joo Heung
    Han, Hyun Ju
    Choi, Yeon A.
    Choi, Ae Ran
    Sohn, Joo Hyuk
    Kim, Seung Il
    PLOS ONE, 2019, 14 (12):
  • [5] Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer
    Rummel, Seth
    Varner, Erika
    Shriver, Craig D.
    Ellsworth, Rachel E.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (01) : 119 - 125
  • [6] Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer
    Seth Rummel
    Erika Varner
    Craig D. Shriver
    Rachel E. Ellsworth
    Breast Cancer Research and Treatment, 2013, 137 : 119 - 125
  • [7] Cisplatin +/- rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer
    Kalra, Maitri
    Tong, Yan
    Jones, David R.
    Walsh, Tom
    Danso, Michael A.
    Ma, Cynthia X.
    Silverman, Paula
    King, Mary-Claire
    Badve, Sunil S.
    Perkins, Susan M.
    Miller, Kathy D.
    NPJ BREAST CANCER, 2021, 7 (01)
  • [8] Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer
    Maitri Kalra
    Yan Tong
    David R. Jones
    Tom Walsh
    Michael A. Danso
    Cynthia X. Ma
    Paula Silverman
    Mary-Claire King
    Sunil S. Badve
    Susan M. Perkins
    Kathy D. Miller
    npj Breast Cancer, 7
  • [9] Molecular profiling comparison of BRCA1/2-mutated and BRCA1/2 non-mutated triple-negative breast cancer (TNBC)
    Arguello, D.
    Abbott, B.
    Reddy, S.
    Gatalica, Z.
    Obeid, E.
    Goldstein, L.
    CANCER RESEARCH, 2016, 76
  • [10] Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
    Tutt, Andrew
    Tovey, Holly
    Cheang, Maggie Chon U.
    Kernaghan, Sarah
    Kilburn, Lucy
    Gazinska, Patrycja
    Owen, Julie
    Abraham, Jacinta
    Barrett, Sophie
    Barrett-Lee, Peter
    Brown, Robert
    Chan, Stephen
    Dowsett, Mitchell
    Flanagan, James M.
    Fox, Lisa
    Grigoriadis, Anita
    Gutin, Alexander
    Harper-Wynne, Catherine
    Hatton, Matthew Q.
    Hoadley, Katherine A.
    Parikh, Jyoti
    Parker, Peter
    Perou, Charles M.
    Roylance, Rebecca
    Shah, Vandna
    Shaw, Adam
    Smith, Ian E.
    Timms, Kirsten M.
    Wardley, Andrew M.
    Wilson, Gregory
    Gillett, Cheryl
    Lanchbury, Jerry S.
    Ashworth, Alan
    Rahman, Nazneen
    Harries, Mark
    Ellis, Paul
    Pinder, Sarah E.
    Bliss, Judith M.
    NATURE MEDICINE, 2018, 24 (05) : 628 - +